Double maintains 1 strategies that include IRON - Disc Medicine, Inc.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -21.27% | $45.74M | -99.96% | 0.00% |
VHC | -9.70% | $34.69M | +74.89% | 0.00% |
K | -7.22% | $28.49B | +32.17% | 2.77% |
SEG | -7.05% | $239.93M | -26.61% | 0.00% |
AQB | -6.47% | $2.96M | -61.58% | 0.00% |
ZCMD | -6.31% | $32.45M | -11.38% | 0.00% |
VSTA | -6.22% | $326.82M | +11.64% | 0.00% |
ED | -6.07% | $36.75B | +5.26% | 3.28% |
AIFU | -5.62% | $9.85M | -95.03% | 0.00% |
MKTX | -5.06% | $8.01B | -1.42% | 1.39% |
CBOE | -5.02% | $22.95B | +20.67% | 1.12% |
BCE | -4.56% | $19.94B | -37.01% | 13.15% |
AGL | -4.12% | $1.06B | -54.30% | 0.00% |
VRCA | -3.70% | $59.36M | -92.99% | 0.00% |
LITB | -3.59% | $21.28M | -72.45% | 0.00% |
BTCT | -3.47% | $25.35M | +93.08% | 0.00% |
T | -3.46% | $196.66B | +57.98% | 4.07% |
MO | -3.45% | $97.80B | +26.35% | 6.94% |
PARAA | -2.89% | $15.22B | +3.06% | 0.88% |
CPSH | -2.88% | $27.45M | +8.62% | 0.00% |
Yahoo
Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-0974 in anemia of myelofibrosis (MF), and additional data from DISC-3405 studies in healthy volunteersManagement will host a corporate update conference call on Monday June 16 at 8:00 am ET / 2:00 pm CEST WATERTOWN, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a cli
Yahoo
WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on Tuesday, May 20th at 9:00 am ET. A live webcast of the fireside chat will be available t
Finnhub
Corporate Presentation May 2025 ...
Finnhub
MF Anemia Day May 9, 2025 ...
Yahoo
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Yahoo
Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPPPlan to initiate Phase 2 study of DISC-3405 in polycythemia vera (PV) in H1 2025Expect data readouts for DISC-0974 program in H2 2025, including initial results of Phase 2 anemia of myelofibrosis (MF) study and multiple dose data from Phase 1b anemia of non-dialysis dependent chronic kidney disease (
Current Value
$46.951 Year Return
Current Value
$46.951 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBTJ | -0.13% | $658.04M | 0.07% |
KRBN | -0.21% | $160.09M | 0.85% |
CMBS | 0.21% | $427.55M | 0.25% |
IEI | -0.49% | $16.09B | 0.15% |
STXT | 0.50% | $134.15M | 0.49% |
STIP | 0.58% | $11.88B | 0.03% |
NEAR | 0.68% | $3.26B | 0.25% |
SHY | -1.03% | $24.03B | 0.15% |
LDUR | 1.18% | $849.09M | 0.5% |
TDTT | -1.19% | $2.47B | 0.18% |
AGZ | 1.21% | $607.46M | 0.2% |
BWX | -1.23% | $1.41B | 0.35% |
IBTK | 1.39% | $431.59M | 0.07% |
VTIP | -1.45% | $14.78B | 0.03% |
GSST | -1.45% | $857.21M | 0.16% |
PALL | -1.68% | $336.74M | 0.6% |
VGIT | 1.70% | $31.33B | 0.04% |
CTA | -1.83% | $1.05B | 0.76% |
SMB | -1.92% | $269.10M | 0.07% |
USDU | 2.00% | $173.44M | 0.5% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NGNE | 46.00% | $276.26M | -42.56% | 0.00% |
IDYA | 44.51% | $1.52B | -58.32% | 0.00% |
ATXS | 43.85% | $225.17M | -57.69% | 0.00% |
ZYME | 43.11% | $810.02M | +22.92% | 0.00% |
KALV | 42.23% | $579.68M | -3.40% | 0.00% |
KYMR | 41.75% | $1.95B | -15.67% | 0.00% |
CRNX | 41.36% | $2.92B | -39.88% | 0.00% |
IMNM | 41.30% | $696.10M | -44.44% | 0.00% |
XNCR | 41.17% | $583.60M | -63.49% | 0.00% |
BNT | 41.13% | $11.98B | +33.22% | 0.00% |
SYRE | 41.08% | $877.54M | -61.53% | 0.00% |
OCUL | 40.58% | $1.14B | +14.35% | 0.00% |
IART | 40.56% | $1.01B | -52.67% | 0.00% |
DHR | 40.51% | $136.66B | -27.90% | 0.60% |
SNDX | 40.46% | $770.13M | -57.22% | 0.00% |
BEAM | 40.29% | $1.73B | -27.49% | 0.00% |
IQV | 40.17% | $24.29B | -40.24% | 0.00% |
ACLX | 39.94% | $3.22B | +10.72% | 0.00% |
TMO | 39.83% | $152.86B | -32.19% | 0.40% |
ROIV | 39.64% | $7.68B | -5.70% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 53.16% | $4.85B | 0.35% |
IBB | 52.84% | $5.22B | 0.45% |
RSPA | 51.20% | $319.03M | 0.29% |
GNOM | 49.69% | $40.65M | 0.5% |
PBE | 48.20% | $214.12M | 0.58% |
BBH | 47.73% | $327.42M | 0.35% |
XPH | 46.89% | $136.58M | 0.35% |
FBT | 46.73% | $994.71M | 0.56% |
QQA | 45.33% | $225.66M | 0.29% |
EFAA | 45.31% | $150.50M | 0.39% |
TJUL | 44.30% | $156.41M | 0.79% |
BALT | 43.75% | $1.44B | 0.69% |
PINK | 43.74% | $131.52M | 0.5% |
PMAR | 43.59% | $605.68M | 0.79% |
JQUA | 43.59% | $6.06B | 0.12% |
HYDB | 43.45% | $1.61B | 0.35% |
CPRJ | 43.42% | $48.43M | 0.69% |
BJUL | 43.23% | $250.71M | 0.79% |
PTH | 43.09% | $96.56M | 0.6% |
ARKG | 43.05% | $944.78M | 0.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CME | 0.09% | $98.74B | +28.80% | 3.84% |
GNE | 0.25% | $478.12M | +14.76% | 1.68% |
DADA | 0.30% | $526.11M | +11.54% | 0.00% |
COR | 0.34% | $55.43B | +28.90% | 0.56% |
PRT | 0.40% | $46.96M | +0.80% | 11.43% |
QXO | 0.44% | $8.44B | -84.99% | 0.00% |
VZ | 0.48% | $183.32B | +8.02% | 6.21% |
DRD | 0.50% | $1.23B | +63.69% | 2.01% |
HEES | -0.67% | $3.52B | +99.54% | 1.15% |
MOH | 0.67% | $17.02B | -8.99% | 0.00% |
KR | -0.72% | $44.68B | +24.17% | 1.89% |
LEU | -0.78% | $1.64B | +120.69% | 0.00% |
CWT | 0.82% | $2.75B | -13.16% | 2.50% |
CMTL | -0.88% | $50.48M | -14.43% | 0.00% |
FENG | -0.93% | $12.15M | +13.64% | 0.00% |
MSEX | -0.93% | $1.02B | -1.01% | 2.34% |
EVH | 0.93% | $1.04B | -62.16% | 0.00% |
FYBR | -1.03% | $9.16B | +36.87% | 0.00% |
PLYA | 1.03% | $1.65B | +57.38% | 0.00% |
EXC | -1.03% | $43.84B | +12.45% | 3.59% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -37.53% | $140.49M | 0.59% |
VIXY | -35.74% | $109.64M | 0.85% |
BTAL | -25.78% | $361.41M | 1.43% |
IVOL | -24.61% | $353.94M | 1.02% |
FTSD | -19.28% | $212.46M | 0.25% |
FXY | -10.41% | $838.61M | 0.4% |
SHYM | -10.24% | $322.93M | 0.35% |
SPTS | -9.22% | $5.76B | 0.03% |
KCCA | -9.12% | $97.18M | 0.87% |
CANE | -8.55% | $10.71M | 0.29% |
SCHO | -7.10% | $10.87B | 0.03% |
UTWO | -7.02% | $387.71M | 0.15% |
IBTH | -6.18% | $1.53B | 0.07% |
XONE | -6.04% | $603.24M | 0.03% |
ULST | -5.87% | $637.77M | 0.2% |
FXE | -5.28% | $525.40M | 0.4% |
VGSH | -5.05% | $22.38B | 0.03% |
IBTG | -5.05% | $1.88B | 0.07% |
CLIP | -4.93% | $1.50B | 0.07% |
STPZ | -4.81% | $446.46M | 0.2% |